Aaron Green Biography and Net Worth

President and Chief Executive Officer of OneMedNet

Aaron Green is a talented senior Healthcare Technology executive with 20+ years of transformational leadership in strategic planning, M&A, product development, service, and support operations. Prior to joining OneMedNet, he served most recently at Change Healthcare, acquired by Optum Insight (a United Health Group company), as Vice President Cloud Solutions.

Before Optum Insight, Green worked for more than 5 years at Change Healthcare as the General Manager of both the Cardiology and Radiology Business Units, as well as the SVP and Chief Growth Officer of the Medical Imaging Group. Prior to Change Healthcare he spent 15 years with McKesson growing to Division Vice President, Sales where he led an organization of executives, salespeople and staff, across the US, Canada, and the US government territories.

Aaron holds a Bachelor of Science in Biochemistry from the University of Victoria, British Columbia, a Systems Analyst Diploma from Royal Roads University, British Columbia, and a Business Administration and Management certificate from the Wharton School.

What is Aaron Green's net worth?: The estimated net worth of Aaron Green is at least $1.32 million as of June 23rd, 2026. Mr. Green owns 1,896,375 shares of OneMedNet stock worth more than $1,316,084 as of September 25th. This net worth approximation does not reflect any other investments that Mr. Green may own. Learn More about Aaron Green's net worth.
How do I contact Aaron Green?: The corporate mailing address for Mr. Green and other OneMedNet executives is Trident Court, 1 Oakcroft Road, Chessington, Surrey, X0, Kt9 1bd. OneMedNet can also be reached via phone at +011442080902009 and via email at [email protected]. Learn More on Aaron Green's contact information.
Has Aaron Green been buying or selling shares of OneMedNet?: Aaron Green has not been actively trading shares of OneMedNet during the past quarter. Most recently, on Tuesday, June 23rd, Aaron Green bought 36,650 shares of OneMedNet stock. The stock was acquired at an average cost of $0.57 per share, with a total value of $20,890.50. Following the completion of the transaction, the chief executive officer now directly owns 1,896,375 shares of the company's stock, valued at $1,080,933.75. Learn More on Aaron Green's trading history.
Are insiders buying or selling shares of OneMedNet?: In the last twelve months, OneMedNet insiders bought shares 14 times. They purchased a total of 4,234,095 shares worth more than $3,223,450.43. In the last twelve months, insiders at the sold shares 2 times. They sold a total of 126,322 shares worth more than $218,296.41. The most recent insider tranaction occured on September, 10th when insider Jeffrey Yu bought 142,857 shares worth more than $89,999.91. Insiders at OneMedNet own 50.2% of the company. Learn More about insider trades at OneMedNet.
Information on this page was last updated on 9/10/2026.

Aaron Green Insider Trading History at OneMedNet

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/23/2026	Buy	36,650	$0.57	$20,890.50	1,896,375
6/15/2026	Buy	18,702	$0.54	$10,099.08	1,859,725
6/12/2026	Buy	36,920	$0.56	$20,675.20	1,841,023
11/18/2025	Sell	61,555	$1.20	$73,866.00	1,804,103
10/22/2025	Sell	64,767	$2.23	$144,430.41	1,865,658

Aaron Green Buying and Selling Activity at OneMedNet

OneMedNet Company Overview

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.

Today's Range

Now: $0.64

$0.62

$0.73

50 Day Range

MA: $0.65

$0.57

$0.78

2 Week Range

Now: $0.64

$0.49

$4.22

Volume

1,100,537 shs

Average Volume

1,896,046 shs

Market Capitalization

$37.89 million

P/E Ratio

N/A

Dividend Yield